Cargando…
DISSEMINATED HERPES ZOSTER VIRUS INFECTION FOLLOWING BARICITINIB IN COVID-19
Autores principales: | KAUR, GURSHARAN, SHRIVASTAVA, MASHU, MUSA NAJMUDDIN, MOHAMMED, ALOYSIUS, MARK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548905/ http://dx.doi.org/10.1016/j.chest.2022.08.792 |
Ejemplares similares
-
BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: SELVARAJ, VIJAIRAM, et al.
Publicado: (2022) -
REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022) -
SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH COVID-19 AND HERPES SIMPLEX VIRUS (HSV): A CASE REPORT
por: VORAKUNTHADA, YUTTIWAT, et al.
Publicado: (2022) -
Herpes Zoster with disseminated lesions. What is it?
por: Gupta, S, et al.
Publicado: (2013) -
Pay It Forward: High School Video-based Instruction Can Disseminate CPR Knowledge in Priority Neighborhoods
por: Del Rios, Marina, et al.
Publicado: (2018)